Oncology play iTeos raises $75M, outlines clinical plans

iTeos Therapeutics S.A. (Gosselies, Belgium) raised $75 million on June 19 in a series B round led by MPM Capital.

Also participating in the round were HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund, Société Régionale d’Investissement de Wallonie (SRIW) and Pfizer Inc. (NYSE:PFE)...